what is the difference between a glp 1 and semaglutide vs. Tirzepatide: Which GLP-1 Wins? Tirzepatide vs semaglutide: dual GLP-1

Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C

Our findings provide new insights into the therapeutic potential of CGA for MI treatment and suggest a promising natural compound for myocardial protection

Di Donato M, Bilancio A, DAmato L, Claudiani P, Oliviero MA, Barone MV, et al

Ophthalmologists evaluating new NAION cases should inquire about semaglutide exposure, and patients diagnosed while on therapy should inform their prescribing clinicians. Consideration of baseline ocular risk factors, including prior NAION or existing optic nerve disease, may also inform treatment discussions. READ MORE: Regaining Vision with Optic Nerve Cell Regeneration Understanding the mechanism The biologic mechanism underlying the association remains uncertain

Keep medicine away from heat, direct light, freezing conditions, children, and pets